Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA

References

• AgnelloLBivonaGLo SassoBGalectin-3 in acute coronary syndromeClin Biochem20175013–1479780328456545
   PubMed Web of Science ®Google Scholar
• Asrar ul HaqMEricksonMRankinJWhelanALate strut fracture within a partially resorbed bioresorbable vascular scaffold: a possible cause of late scaffold thrombosis and acute coronary syndromeHeart Lung Circ2017264e26e2827884634
   PubMed Web of Science ®Google Scholar
• LaineMFrereCCuissetTPotential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromesInt J Cardiol201622049650027390976
   PubMed Web of Science ®Google Scholar
• deVeberGAKirtonABoothFAEpidemiology and outcomes of arterial ischemic stroke in children: the Canadian pediatric ischemic stroke registryPediatr Neurol201769587028254555
   PubMed Web of Science ®Google Scholar
• ArnaezJGarcia-AlixAExtracerebral thrombosis in symptomatic neonatal arterial ischemic strokeEur J Pediatr Neurol2017214687688
   PubMed Web of Science ®Google Scholar
• YuanZVossEADeFalcoFJRisk prediction for ischemic stroke and transient ischemic attack in patients without atrial fibrillation: a retrospective cohort studyJ Stroke Cerebrovasc Dis20172681721173128392100
   PubMed Web of Science ®Google Scholar
• van der SpuyWJAugustineTNUltrastructural investigation of the time-dependent relationship between breast cancer cells and thrombosis inductionMicron201690596327595902
   PubMed Web of Science ®Google Scholar
• CastamanGRisk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors)Thromb Res2016140Suppl 1S89S9227067986
   PubMedGoogle Scholar
• ChaDJAlfreyEJDesaiDMMacConmaraMHwangCSIncreased risk of vascular thrombosis in pediatric liver transplant recipients with thrombophiliaJ Surg Res2015199267167526392201
   PubMed Web of Science ®Google Scholar
• FunabashiNTakaokaHOzawaKCombined ostium secundum type ASD and pulmonary arterial thromboembolism causing pulmonary artery enlargement, pulmonary hypertension and recurrent paradoxical cerebral embolism due to deep venous thrombosisInt J Cardiol201620730330726814633
   PubMed Web of Science ®Google Scholar
• Rodriguez-ZunigaMJMCortez-FrancoFQuijano-GomeroEAssociation of psoriasis and metabolic syndrome in Latin America: a systematic review and meta-analysisActas Dermosifiliogr2017108432633428117050
   PubMedGoogle Scholar
• O’NeillSBohlMGregersenSHermansenKO’DriscollLBlood-based biomarkers for metabolic syndromeTrends Endocrinol Metab201627636337427150849
   PubMed Web of Science ®Google Scholar
• KimHLLeeJMSeoJBThe effects of metabolic syndrome and its components on arterial stiffness in relation to genderJ Cardiol201565324324925034706
   PubMed Web of Science ®Google Scholar
• WileyJFCarringtonMJA metabolic syndrome severity score: a tool to quantify cardio-metabolic risk factorsPrev Med20168818919527095322
   PubMed Web of Science ®Google Scholar
• ChenQZhangYDingDMetabolic syndrome and its individual components with mortality among patients with coronary heart diseaseInt J Cardiol201622481427599384
   PubMed Web of Science ®Google Scholar
• AbbottETruongJRadaKSuperior mesenteric artery thrombosisVis J Emerg Med201771314
   Google Scholar
• ChenXFanXTanJPalladin is involved in platelet activation and arterial thrombosisThromb Res20171491827865965
   PubMed Web of Science ®Google Scholar
• CzepluchFSMeierJBinderCHasenfussGSchäferKCCL5 deficiency reduces neointima formation following arterial injury and thrombosis in apolipoprotein E-deficient miceThromb Res201614413614327337700
   PubMed Web of Science ®Google Scholar
• FoleyJHWaltonBLAlemanMMComplement activation in arterial and venous thrombosis is mediated by plasminEBioMedicine2016517518227077125
   PubMed Web of Science ®Google Scholar
• Vardon BounesFMujalliACenacCThe importance of blood platelet lipid signaling in thrombosis and in sepsisAdv Biol Regul Epub2017929
   PubMedGoogle Scholar
• BhushanIAlabbasASistlaJCSaraswatRDesaiURGuptaRBHeparin depolymerization by immobilized heparinase: a reviewInt J Biol Macromol20179972173028300590
   PubMed Web of Science ®Google Scholar
• LiQHanXLanXInhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemiaNeurobiol Dis201710817318228830843
   PubMed Web of Science ®Google Scholar
• EbbenHPNederhoedJHSlikkerveerJTherapeutic application of contrast-enhanced ultrasound and low-dose urokinase for throm-bolysis in a porcine model of acute peripheral arterial occlusionJ Vasc Surg201562247748524768365
   PubMed Web of Science ®Google Scholar
• EltayebTYMMohamedMSElburAIElsayedASASatisfaction with and adherence to warfarin treatment: a cross-sectional study among Sudanese patientsJ Saudi Heart Assoc201729316917528652670
   PubMedGoogle Scholar
• FurugohriTMorishimaYParadoxical enhancement of the intrinsic pathway-induced thrombin generation in human plasma by melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, or heparinThromb Res2015136365866226188924
   PubMed Web of Science ®Google Scholar
• LemarchantSDocagneFEmeryEVivienDAliCRubioMtPA in the injured central nervous system: different scenarios starring the same actor?Neuropharmacology201262274975622079561
   PubMed Web of Science ®Google Scholar
• SchindewolfMGobstCKrollHHigh incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancyJ Allergy Clin Immunol2013132113113923726261
   PubMed Web of Science ®Google Scholar
• HarenbergJPast, present, and future perspectives of heparins in clinical settings and the role of impaired renal functionInt J Cardiol2016212Suppl 1S10S1327264865
   PubMedGoogle Scholar
• KimYJKimSKChoSYSafety of acupuncture treatments for patients taking warfarin or antiplatelet medications: retrospective chart review studyEur J Integr Med201464492496
   Web of Science ®Google Scholar
• ŠupeSPoljakovićZBožinaTLjevakJMacolić ŠarinićVBožinaNClinical application of genotype-guided dosing of warfarin in patients with acute strokeArch Med Res201546426527325989350
   PubMed Web of Science ®Google Scholar
• IchiharaNIshigamiTUmemuraSEffect of impaired renal function on the maintenance dose of warfarin in Japanese patientsJ Cardiol201565317818425442049
   PubMed Web of Science ®Google Scholar
• Abu FanneRNassarTYarovoiSBlood-brain barrier permeability and tPA-mediated neurotoxicityNeuropharmacology201058797298020060006
   PubMed Web of Science ®Google Scholar
• JinHTanHZhaoLUltrasound-triggered thrombolysis using urokinase-loaded nanogelsInt J Pharm2012434138439022683455
   PubMedGoogle Scholar
• NoelNDutastaFCostedoat-ChalumeauNSafety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndromeAutoimmun Rev201514868068525864630
   PubMed Web of Science ®Google Scholar
• GohMKimYGwonKMinKHwangYTaeGIn situ formation of injectable and porous heparin-based hydrogelCarbohydr Polym201717499099828821157
   PubMed Web of Science ®Google Scholar
• BiFZhangJSuYTangYCLiuJNChemical conjugation of uroki-nase to magnetic nanoparticles for targeted thrombolysisBiomaterials200930285125513019560812
   PubMed Web of Science ®Google Scholar
• DuehrkopCLeneweitGHeyderCDevelopment and char-acterization of an innovative heparin coating to stabilize and protect liposomes against adverse immune reactionsColloids Surf B Biointerfaces201614157658326897551
   PubMed Web of Science ®Google Scholar
• ChengSZhangXWangWA class of novel N-(3S-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)-L-amino acid derivatives: their synthesis, anti-thrombotic activity evaluation, and 3D QSAR analysisEur J Med Chem200944124904491919729231
   PubMed Web of Science ®Google Scholar
• JinSMWangYNZhuHMNanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptideACS Nano2013797664767323931063
   PubMed Web of Science ®Google Scholar
• YangGDZhuHMZhaoMThe application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of actionMol Biosyst20128102672267922801714
   PubMedGoogle Scholar
• WuJZhuHZhaoMIQCA-TASS: a nano-scaled P-selectin inhibitor capable of targeting thrombus and releasing IQCA/TARGD(S)S in vivoJ Mater Chem B201755917927
   PubMed Web of Science ®Google Scholar